Literature DB >> 12879149

Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes.

Marc Y Donath1, Joachim Størling, Kathrin Maedler, Thomas Mandrup-Poulsen.   

Abstract

Pancreatic islet beta-cell death occurs in type 1 and 2 diabetes mellitus, leading to absolute or relative insulin deficiency. beta-cell death in type 1 diabetes is due predominantly to autoimmunity. In type 2 diabetes beta-cell death occurs as the combined consequence of increased circulating glucose and saturated fatty acids together with adipocyte secreted factors and chronic activation of the innate immune system. In both diabetes types intra-islet inflammatory mediators seem to trigger a final common pathway leading to beta-cell apoptosis. Therefore anti-inflammatory therapeutic approaches designed to block beta-cell apoptosis could be a significant new development in type 1 and 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12879149     DOI: 10.1007/s00109-003-0450-y

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  154 in total

Review 1.  Islet growth and development in the adult.

Authors:  S Bonner-Weir
Journal:  J Mol Endocrinol       Date:  2000-06       Impact factor: 5.098

2.  Invited comment on W. Ebstein: On the therapy of diabetes mellitus, in particular on the application of sodium salicylate.

Authors:  Wilhelm Ebstein
Journal:  J Mol Med (Berl)       Date:  2002-10       Impact factor: 4.599

3.  Cytokines suppress human islet function irrespective of their effects on nitric oxide generation.

Authors:  D L Eizirik; S Sandler; N Welsh; M Cetkovic-Cvrlje; A Nieman; D A Geller; D G Pipeleers; K Bendtzen; C Hellerström
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

4.  Effects of insulin in relatives of patients with type 1 diabetes mellitus.

Authors: 
Journal:  N Engl J Med       Date:  2002-05-30       Impact factor: 91.245

5.  Short-term exposure of rat pancreatic islets to human interleukin-1 beta increases cellular uptake of calcium.

Authors:  L A Borg; D L Eizirik
Journal:  Immunol Lett       Date:  1990-12       Impact factor: 3.685

6.  Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis.

Authors:  H Heimberg; Y Heremans; C Jobin; R Leemans; A K Cardozo; M Darville; D L Eizirik
Journal:  Diabetes       Date:  2001-10       Impact factor: 9.461

7.  Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death.

Authors:  C Bonny; A Oberson; S Negri; C Sauser; D F Schorderet
Journal:  Diabetes       Date:  2001-01       Impact factor: 9.461

8.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

9.  FLIP switches Fas-mediated glucose signaling in human pancreatic beta cells from apoptosis to cell replication.

Authors:  Kathrin Maedler; Adriano Fontana; Frédéric Ris; Pavel Sergeev; Christian Toso; José Oberholzer; Roger Lehmann; Felix Bachmann; Andrea Tasinato; Giatgen A Spinas; Philippe A Halban; Marc Y Donath
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

Review 10.  Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

Authors:  Joseph L Evans; Ira D Goldfine; Betty A Maddux; Gerold M Grodsky
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

View more
  128 in total

1.  The nuclear orphan receptor Nur77 is a lipotoxicity sensor regulating glucose-induced insulin secretion in pancreatic β-cells.

Authors:  Olivier Briand; Audrey Helleboid-Chapman; Maheul Ploton; Nathalie Hennuyer; Rodolphe Carpentier; François Pattou; Brigitte Vandewalle; Ericka Moerman; Valery Gmyr; Julie Kerr-Conte; Jérôme Eeckhoute; Bart Staels; Philippe Lefebvre
Journal:  Mol Endocrinol       Date:  2012-02-02

2.  Immune modulators in disease: integrating knowledge from the biomedical literature and gene expression.

Authors:  Nophar Geifman; Sanchita Bhattacharya; Atul J Butte
Journal:  J Am Med Inform Assoc       Date:  2015-12-11       Impact factor: 4.497

3.  Protective effects of pioglitazone against immunoglobulin deposition on heart of streptozotocin-induced diabetic rats.

Authors:  M Yuan; M Qiu; J Cui; X Zhang; P Zhang
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

4.  Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans.

Authors:  J J Meier; T G K Breuer; R C Bonadonna; A Tannapfel; W Uhl; W E Schmidt; H Schrader; B A Menge
Journal:  Diabetologia       Date:  2012-05       Impact factor: 10.122

Review 5.  Blockade of interleukin 1 in type 1 diabetes mellitus.

Authors:  Thomas Mandrup-Poulsen; Linda Pickersgill; Marc Yves Donath
Journal:  Nat Rev Endocrinol       Date:  2010-03       Impact factor: 43.330

6.  Epistasis between hyperglycemic QTLs revealed in a double congenic of the OLETF rat.

Authors:  Hiroyuki Kose; Yoshimi Bando; Keisuke Izumi; Takahisa Yamada; Kozo Matsumoto
Journal:  Mamm Genome       Date:  2007-08-21       Impact factor: 2.957

7.  Upregulation of phagocyte-like NADPH oxidase by cytokines in pancreatic beta-cells: attenuation of oxidative and nitrosative stress by 2-bromopalmitate.

Authors:  Abiy M Mohammed; Khadija Syeda; Timothy Hadden; Anjaneyulu Kowluru
Journal:  Biochem Pharmacol       Date:  2012-10-23       Impact factor: 5.858

8.  Altering β-cell number through stable alteration of miR-21 and miR-34a expression.

Authors:  Marie Balslev Backe; Guy Wayne Novotny; Dan Ploug Christensen; Lars Groth Grunnet; Thomas Mandrup-Poulsen
Journal:  Islets       Date:  2014       Impact factor: 2.694

9.  Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation.

Authors:  Marianne Böni-Schnetzler; Jeffrey Thorne; Géraldine Parnaud; Lorella Marselli; Jan A Ehses; Julie Kerr-Conte; Francois Pattou; Philippe A Halban; Gordon C Weir; Marc Y Donath
Journal:  J Clin Endocrinol Metab       Date:  2008-07-29       Impact factor: 5.958

Review 10.  Current views on type 2 diabetes.

Authors:  Yi Lin; Zhongjie Sun
Journal:  J Endocrinol       Date:  2009-09-21       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.